Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125574081 | 12557408 | 1 | I | 2006 | 20160624 | 20160714 | 20160714 | PER | US-009507513-1606USA012771 | MERCK | 76.50 | YR | F | Y | 81.63000 | KG | 20160714 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125574081 | 12557408 | 1 | SS | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Oral | U | 0 | TABLET | |||||||||
| 125574081 | 12557408 | 2 | PS | PRINIVIL | LISINOPRIL | 1 | Oral | U | 19558 | TABLET | |||||||||
| 125574081 | 12557408 | 3 | SS | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 10 MG CUTTING IN A HALF TABLET ORALLY EVERY EVENING | 0 | 5 | MG | QD | |||||||
| 125574081 | 12557408 | 4 | SS | NORVASC | AMLODIPINE BESYLATE | 1 | Oral | 5 MG, UNK | 0 | 5 | MG | ||||||||
| 125574081 | 12557408 | 5 | SS | SEPTRA DS | SULFAMETHOXAZOLETRIMETHOPRIM | 1 | Y | 0 | |||||||||||
| 125574081 | 12557408 | 6 | SS | PARAFON FORTE | CHLORZOXAZONE | 1 | Y | 0 | |||||||||||
| 125574081 | 12557408 | 7 | SS | XYLOCAINE | LIDOCAINE HYDROCHLORIDE | 1 | Y | 0 | |||||||||||
| 125574081 | 12557408 | 8 | SS | EPINEPHRINE. | EPINEPHRINE | 1 | Y | 0 | |||||||||||
| 125574081 | 12557408 | 9 | SS | XALATAN | LATANOPROST | 1 | U | 0 | |||||||||||
| 125574081 | 12557408 | 10 | SS | LUMIGAN | BIMATOPROST | 1 | U | 0 | |||||||||||
| 125574081 | 12557408 | 11 | SS | AMLODIPINE BESYLATE. | AMLODIPINE BESYLATE | 1 | U | 0 | |||||||||||
| 125574081 | 12557408 | 12 | SS | TOPROL XL | METOPROLOL SUCCINATE | 1 | U | 0 | |||||||||||
| 125574081 | 12557408 | 13 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | U | 0 | |||||||||||
| 125574081 | 12557408 | 14 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | U | 0 | |||||||||||
| 125574081 | 12557408 | 15 | C | ATENOLOL. | ATENOLOL | 1 | 25 MG, QPM | U | 0 | 25 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125574081 | 12557408 | 1 | Blood pressure management |
| 125574081 | 12557408 | 2 | Blood pressure management |
| 125574081 | 12557408 | 3 | Hypertension |
| 125574081 | 12557408 | 5 | Urinary tract infection |
| 125574081 | 12557408 | 6 | Muscle relaxant therapy |
| 125574081 | 12557408 | 9 | Glaucoma |
| 125574081 | 12557408 | 10 | Glaucoma |
| 125574081 | 12557408 | 12 | Blood pressure management |
| 125574081 | 12557408 | 13 | Dyspepsia |
| 125574081 | 12557408 | 14 | Irritable bowel syndrome |
| 125574081 | 12557408 | 15 | Pulse abnormal |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125574081 | 12557408 | Adverse event | |
| 125574081 | 12557408 | Back pain | |
| 125574081 | 12557408 | Bladder disorder | |
| 125574081 | 12557408 | Burning sensation | |
| 125574081 | 12557408 | Cystitis | |
| 125574081 | 12557408 | Drug hypersensitivity | |
| 125574081 | 12557408 | Epistaxis | |
| 125574081 | 12557408 | Feeling abnormal | |
| 125574081 | 12557408 | Palpitations | |
| 125574081 | 12557408 | Paranasal sinus discomfort | |
| 125574081 | 12557408 | Rash | |
| 125574081 | 12557408 | Toxicity to various agents |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |